These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 31737675)

  • 1. Utility of Inflammatory Markers in Predicting Hepatocellular Carcinoma Survival after Liver Transplantation.
    Ismael MN; Forde J; Milla E; Khan W; Cabrera R
    Biomed Res Int; 2019; 2019():7284040. PubMed ID: 31737675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte to monocyte ratio and neutrophil to lymphocyte ratio are superior inflammation-based predictors of recurrence in patients with hepatocellular carcinoma after hepatic resection.
    Yang T; Zhu J; Zhao L; Mai K; Ye J; Huang S; Zhao Y
    J Surg Oncol; 2017 May; 115(6):718-728. PubMed ID: 28127774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte/granulocyte to lymphocyte ratio and the MELD score as predictors for early recurrence of hepatocellular carcinoma after trans-arterial chemoembolization.
    Elalfy H; Besheer T; El-Maksoud MA; Farid K; Elegezy M; El Nakib AM; El-Aziz MA; El-Khalek AA; El-Morsy A; Elmokadem A; Elsamanoudy AZ; El-Bendary M
    Br J Biomed Sci; 2018 Oct; 75(4):187-191. PubMed ID: 29991324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma.
    Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
    J Surg Res; 2015 Sep; 198(1):73-9. PubMed ID: 26022997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of preoperative systemic inflammatory biomarkers in patients with hepatocellular carcinoma after microwave ablation and establishment of a nomogram.
    Wang S; Deng Y; Yu X; Zhang XW; Huo CL; Sun ZG; Chang H
    Sci Rep; 2021 Jul; 11(1):13814. PubMed ID: 34226605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma.
    Zheng J; Seier K; Gonen M; Balachandran VP; Kingham TP; D'Angelica MI; Allen PJ; Jarnagin WR; DeMatteo RP
    Ann Surg Oncol; 2017 Nov; 24(12):3706-3714. PubMed ID: 28840521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma.
    Li P; Huang W; Wang F; Ke YF; Gao L; Shi KQ; Zhou MT; Chen BC
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30254101
    [No Abstract]   [Full Text] [Related]  

  • 9. The Severity of Liver Fibrosis Influences the Prognostic Value of Inflammation-Based Scores in Hepatitis B-Associated Hepatocellular Carcinoma.
    Wang Q; Blank S; Fiel MI; Kadri H; Luan W; Warren L; Zhu A; Deaderick PA; Sarpel U; Labow DM; Hiotis SP
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1125-32. PubMed ID: 26159441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model for end-stage liver disease-dependent prognostic capacity of platelet-to-lymphocyte ratio following liver transplantation for hepatocellular carcinoma.
    He C; Shen W; Lin Z; Hu Z; Li H; Chen H; Yang M; Yang X; Zhuo J; Pan L; Wei X; Zhuang L; Zheng S; Lu D; Xu X
    Transpl Immunol; 2024 Aug; 85():102071. PubMed ID: 38866187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.
    Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
    J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
    Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
    Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation.
    Xia W; Ke Q; Wang Y; Wang W; Zhang M; Shen Y; Wu J; Xu X; Zheng S
    World J Surg Oncol; 2015 Feb; 13():60. PubMed ID: 25885777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection.
    Yang HJ; Jiang JH; Liu QA; Zhou CM; Du YF; Wu T; Chen NZ; Xiang BD
    Tumour Biol; 2017 Jun; 39(6):1010428317707375. PubMed ID: 28639906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within Milan criteria.
    Parisi I; Tsochatzis E; Wijewantha H; Rodríguez-Perálvarez M; De Luca L; Manousou P; Fatourou E; Pieri G; Papastergiou V; Davies N; Yu D; Luong T; Dhillon AP; Thorburn D; Patch D; O'Beirne J; Meyer T; Burroughs AK
    Liver Transpl; 2014 Nov; 20(11):1327-35. PubMed ID: 25088400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE.
    Schobert IT; Savic LJ; Chapiro J; Bousabarah K; Chen E; Laage-Gaupp F; Tefera J; Nezami N; Lin M; Pollak J; Schlachter T
    Eur Radiol; 2020 Oct; 30(10):5663-5673. PubMed ID: 32424595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.
    Xiao GQ; Yang JY; Yan LN
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):588-95. PubMed ID: 26663006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer.
    Lai Q; Castro Santa E; Rico Juri JM; Pinheiro RS; Lerut J
    Transpl Int; 2014 Jan; 27(1):32-41. PubMed ID: 24118272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation.
    Xiao GQ; Liu C; Liu DL; Yang JY; Yan LN
    World J Gastroenterol; 2013 Dec; 19(45):8398-407. PubMed ID: 24363533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.